CN1302780C - 烷基胆碱磷酸在制备用抗肿瘤药之前和/或期间治疗肿瘤的药物中的应用 - Google Patents

烷基胆碱磷酸在制备用抗肿瘤药之前和/或期间治疗肿瘤的药物中的应用 Download PDF

Info

Publication number
CN1302780C
CN1302780C CNB038181010A CN03818101A CN1302780C CN 1302780 C CN1302780 C CN 1302780C CN B038181010 A CNB038181010 A CN B038181010A CN 03818101 A CN03818101 A CN 03818101A CN 1302780 C CN1302780 C CN 1302780C
Authority
CN
China
Prior art keywords
preparation
application
treatment
alkyl
benign
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB038181010A
Other languages
English (en)
Chinese (zh)
Other versions
CN1671397A (zh
Inventor
J·恩格尔
E·京特
H·辛德曼恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeterna Zentaris GmbH
Original Assignee
Zentaris AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris AG filed Critical Zentaris AG
Publication of CN1671397A publication Critical patent/CN1671397A/zh
Application granted granted Critical
Publication of CN1302780C publication Critical patent/CN1302780C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CNB038181010A 2002-07-30 2003-07-29 烷基胆碱磷酸在制备用抗肿瘤药之前和/或期间治疗肿瘤的药物中的应用 Expired - Fee Related CN1302780C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39961502P 2002-07-30 2002-07-30
US60/399,615 2002-07-30

Publications (2)

Publication Number Publication Date
CN1671397A CN1671397A (zh) 2005-09-21
CN1302780C true CN1302780C (zh) 2007-03-07

Family

ID=31495746

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038181010A Expired - Fee Related CN1302780C (zh) 2002-07-30 2003-07-29 烷基胆碱磷酸在制备用抗肿瘤药之前和/或期间治疗肿瘤的药物中的应用

Country Status (26)

Country Link
US (3) US8389497B2 (enExample)
EP (2) EP1545553B1 (enExample)
JP (1) JP2005535688A (enExample)
KR (3) KR101066804B1 (enExample)
CN (1) CN1302780C (enExample)
AR (1) AR040717A1 (enExample)
AT (1) ATE516036T1 (enExample)
AU (2) AU2003253350B2 (enExample)
BR (1) BR0313048A (enExample)
CA (1) CA2493023C (enExample)
CY (1) CY1111902T1 (enExample)
DK (1) DK1545553T3 (enExample)
ES (1) ES2369535T3 (enExample)
HR (1) HRP20050184B1 (enExample)
IL (1) IL166329A (enExample)
MX (1) MXPA05001203A (enExample)
NO (1) NO335196B1 (enExample)
NZ (1) NZ538428A (enExample)
PL (1) PL375493A1 (enExample)
PT (1) PT1545553E (enExample)
RU (1) RU2005105693A (enExample)
SI (1) SI1545553T1 (enExample)
TW (1) TWI332007B (enExample)
UA (1) UA82322C2 (enExample)
WO (1) WO2004012744A1 (enExample)
ZA (1) ZA200500453B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8383605B2 (en) 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
TWI332007B (en) 2002-07-30 2010-10-21 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals
DE10324911B4 (de) 2003-05-30 2005-08-18 Siemens Ag Röntgenvorrichtung mit partiellem digitalem Detektor und Verfahren zum Betrieb einer solchen
WO2006081452A2 (en) * 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
WO2009018233A1 (en) * 2007-07-30 2009-02-05 Ardea Biosciences, Inc. Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same
JP5232009B2 (ja) * 2005-12-19 2013-07-10 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用
EP1800684A1 (en) * 2005-12-20 2007-06-27 Zentaris GmbH Novel alkyl phospholipid derivatives and uses thereof
CN101340918B (zh) * 2005-12-19 2012-10-03 阿特纳赞塔里斯有限公司 具有降低细胞毒性的新烷基磷脂衍生物及其用途
US8703179B2 (en) 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
MX2011006167A (es) * 2008-12-11 2011-07-28 Abraxis Bioscience Llc Combinaciones y modos de administracion de agentes terapeuticos y terapia de combinacion.
MX2011011596A (es) 2010-03-31 2012-02-01 Keryx Biopharmaceuticals Inc Perifosina y capecitabina como un tratamiento combinado para cancer.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59205998D1 (de) * 1991-07-04 1996-05-23 Asta Medica Ag Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
US5942639A (en) * 1991-07-04 1999-08-24 Asta Medica Aktiengesellschaft Process for the preparation of alkylphosphocholines and the production thereof in pure form
US6172050B1 (en) * 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
JP3079993B2 (ja) * 1996-03-27 2000-08-21 日本電気株式会社 真空マイクロデバイスおよびその製造方法
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
PL189654B1 (pl) * 1998-01-22 2005-09-30 Zentaris Gmbh Zastosowanie miltefosyny do wytwarzania leków
PT1135193E (pt) * 1998-12-04 2003-01-31 Max Delbrueck Centrum Agentes para o tratamento de tumores a base de lipossomas e compreendendo tamoxifeno
CA2356736A1 (en) * 1998-12-21 2000-06-29 Inkeysa. S.A. Use of etherlysophospholipids as antiinflammatory agents
EP2762140B1 (en) * 2001-02-19 2017-03-22 Novartis AG Treatment of solid brain tumours with a rapamycin derivative
PL365285A1 (en) * 2001-03-23 2004-12-27 Shire Biochem Inc. Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
WO2003005522A1 (es) 2001-07-04 2003-01-16 Acuna Arturo Tapones para sellado de ductos para redes electricas, telefonicas y de fibra optica.
US20060084612A1 (en) * 2002-01-02 2006-04-20 Geroni Maria C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
TWI332007B (en) 2002-07-30 2010-10-21 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals
WO2005000318A2 (en) * 2003-06-23 2005-01-06 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
WO2006081452A2 (en) 2005-01-28 2006-08-03 Robert Birch Co-administration of perifosine with chemotherapeutics
CN101340918B (zh) * 2005-12-19 2012-10-03 阿特纳赞塔里斯有限公司 具有降低细胞毒性的新烷基磷脂衍生物及其用途
MX2011011596A (es) * 2010-03-31 2012-02-01 Keryx Biopharmaceuticals Inc Perifosina y capecitabina como un tratamiento combinado para cancer.

Also Published As

Publication number Publication date
HRP20050184A2 (en) 2005-04-30
PL375493A1 (en) 2005-11-28
DK1545553T3 (da) 2011-09-12
US8389497B2 (en) 2013-03-05
JP2005535688A (ja) 2005-11-24
IL166329A0 (en) 2006-01-15
NO20051040L (no) 2005-02-25
US8507710B2 (en) 2013-08-13
IL166329A (en) 2012-08-30
US20100190738A1 (en) 2010-07-29
KR20130016413A (ko) 2013-02-14
TWI332007B (en) 2010-10-21
CY1111902T1 (el) 2015-11-04
EP1545553A1 (de) 2005-06-29
US20100189784A1 (en) 2010-07-29
SI1545553T1 (sl) 2011-09-30
HRP20050184B1 (hr) 2014-04-11
KR20110102485A (ko) 2011-09-16
US8551977B2 (en) 2013-10-08
RU2005105693A (ru) 2005-07-10
KR101066804B1 (ko) 2011-09-22
AU2003253350B2 (en) 2008-06-26
CA2493023A1 (en) 2004-02-12
ATE516036T1 (de) 2011-07-15
NO335196B1 (no) 2014-10-20
PT1545553E (pt) 2011-09-12
WO2004012744A1 (de) 2004-02-12
ZA200500453B (en) 2005-08-31
KR20050026028A (ko) 2005-03-14
EP2301551A1 (de) 2011-03-30
TW200404073A (en) 2004-03-16
MXPA05001203A (es) 2005-06-08
BR0313048A (pt) 2005-06-14
CN1671397A (zh) 2005-09-21
CA2493023C (en) 2012-01-31
NZ538428A (en) 2006-09-29
AR040717A1 (es) 2005-04-20
EP1545553B1 (de) 2011-07-13
AU2008203060B2 (en) 2011-04-21
ES2369535T3 (es) 2011-12-01
AU2003253350A1 (en) 2004-02-23
HK1080751A1 (en) 2006-05-04
US20040097470A1 (en) 2004-05-20
AU2008203060A1 (en) 2008-07-31
UA82322C2 (uk) 2008-04-10

Similar Documents

Publication Publication Date Title
US8507710B2 (en) Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
CN1148181C (zh) 黄酮木酯素在制备对子宫、卵巢和乳腺具有抗增殖活性的药物中的应用
CN1349406A (zh) 含吗啉蒽环类化生物和抗癌剂的联合制剂
US8383605B2 (en) Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
KR101572529B1 (ko) 암 치료를 위한 육산화사비소의 병용요법
HK1080751B (en) Use of alkyl phosphocholines in combination with antitumor medicaments
KR20030019612A (ko) 골전이 치료에서 에스트라무스틴 포스페이트의 용도
AU2011204918B2 (en) Use of alkylphosphocholines in combination with antitumor medicaments
AU2016340017A1 (en) Compositions and methods for the treatment of diseases involving mucin
JP7470376B2 (ja) 顎下腺の萎縮抑制剤及び創傷治癒促進剤
CA2436332A1 (en) Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammals
EP1599210A1 (en) A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent
HK1055901A (en) Use of estramustine phosphate in the treatment of bone metastasis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1080751

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee
CP01 Change in the name or title of a patent holder

Address after: Frankfurt, Germany

Patentee after: Zentaris GmbH

Address before: Frankfurt, Germany

Patentee before: Zentaris GmbH

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070307

Termination date: 20170729